| Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase studied in …STUDIED_INderived10 of 28show all (up to 200) |
|---|
| → studied in | NCT07469891Phase 1 · recruiting A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms · condition mapped ALIAS · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04717414Phase 3 · active not recruiting An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions · condition mapped ALIAS · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03441113Phase 2 · active not recruiting Extended Access of Momelotinib in Adults With Myelofibrosis · condition mapped ALIAS · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04517851Phase 2 · active not recruiting Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis · condition mapped ONTOLOGY_EXACT · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06351631Phase 3 · recruiting A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) · condition mapped ALIAS · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787487Phase 2 · completed Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07362225recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) · condition mapped ALIAS · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551066Phase 3 · terminated To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) · condition mapped ALIAS · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551053Phase 3 · terminated To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) · condition mapped ALIAS · 28 trials mapped (10 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |